Literature DB >> 8256656

Tumor necrosis factor alpha modulates parathyroid hormone action in UMR-106-01 osteoblastic cells.

C D Hanevold1, D T Yamaguchi, S C Jordan.   

Abstract

Tumor necrosis factor (TNF-alpha) has been shown to play an important role in local control of bone remodeling. The interaction of TNF-alpha and PTH was evaluated in UMR-106-01 cells, a phenotypic osteoblastic osteosarcoma cell line. We examined the influence of TNF-alpha on the two signal transduction systems triggered by PTH in UMR-106-01 cells, adenylate cyclase and free cytosolic calcium ([Ca2+]i). cAMP generation was inhibited in TNF-alpha-pretreated cells by 69, 61, 34, and 21% at PTH concentrations of 0.1, 1, 10, and 100 nM, respectively. Inhibition was seen at TNF-alpha doses of 100-1500 units/ml after a minimum incubation time of 12 h. TNF-alpha inhibition of the PTH-stimulated increase in [Ca2+]i was even more pronounced: treated cells showed no change in baseline [Ca2+]i after stimulation with 40 nM PTH. Treatment with TNF-alpha was also found to inhibit both arms of the PTH response in the nontransformed osteoblastic cell line, MC3T3-E1. TNF-alpha treatment did not alter cAMP generation in response to PGE2. TNF-alpha inhibition of the PTH-stimulated cAMP response was reversed completely by addition of cholera toxin (5 micrograms/ml) and partially by forskolin (10 microM) but not pertussis toxin (100 and 500 ng/ml). Scatchard analysis using PTHrP revealed that TNF-alpha treatment reduced the number of receptors but had no effect on KD. These findings suggest that TNF-alpha inhibits the osteoblastic response to PTH at least in part because of a reduction in receptor number. Further investigation is indicated to provide insight into the interaction of calciotropic hormones and cytokines in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8256656     DOI: 10.1002/jbmr.5650081006

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  4 in total

Review 1.  Vitamin D in HIV-Infected Patients.

Authors:  Jordan E Lake; John S Adams
Journal:  Curr HIV/AIDS Rep       Date:  2011-09       Impact factor: 5.071

2.  Cross-sectional study of vitamin D levels, immunologic and virologic outcomes in HIV-infected adults.

Authors:  Allison Bearden; Cybele Abad; Ron Gangnon; James M Sosman; Neil Binkley; Nasia Safdar
Journal:  J Clin Endocrinol Metab       Date:  2013-03-01       Impact factor: 5.958

3.  Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis.

Authors:  Kurt Redlich; Birgit Görtz; Silvia Hayer; Jochen Zwerina; Nicholas Doerr; Paul Kostenuik; Helga Bergmeister; George Kollias; Günter Steiner; Josef S Smolen; Georg Schett
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

4.  Hypovitaminosis D Is Associated with Higher Levels of Inflammatory Cytokines and with HAM/TSP in HTLV-Infected Patients.

Authors:  Elaine Coutinho Netto; Alfredo Carlos Silva; Célia Pedroso; Carlos Brites
Journal:  Viruses       Date:  2021-11-04       Impact factor: 5.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.